(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 24.79% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.92%.
Seer's revenue in 2025 is $16,288,000.On average, 1 Wall Street analysts forecast SEER's revenue for 2025 to be $990,445,580, with the lowest SEER revenue forecast at $990,445,580, and the highest SEER revenue forecast at $990,445,580. On average, 1 Wall Street analysts forecast SEER's revenue for 2026 to be $1,177,492,185, with the lowest SEER revenue forecast at $1,177,492,185, and the highest SEER revenue forecast at $1,177,492,185.
In 2027, SEER is forecast to generate $1,867,085,694 in revenue, with the lowest revenue forecast at $1,867,085,694 and the highest revenue forecast at $1,867,085,694.